AI Is Not a Labor Crisis. It Is a Meaning Crisis.” is the name of a heavily quoted article by Sam Lessin of Slow Ventures.

Analysts are intrigued by SPY001’s early efficacy and dosing convenience, noting that the drug could compete with therapies ...

For more than a century, universities have been among humanity’s most transformative institutions. They powered the ...

Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic ...

Vitamin B1, aka thiamin, helps supports energy metabolism and brain function. These are the healthiest thiamin-rich foods to ...

Mezagitamab is a fully human IgG1 monoclonal antibody that targets CD38, which is highly expressed on the surface of plasma ...

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel ...

Titles like BioShock and Portal 2 are among the all-time greatest video games ever made, building legacies that certify them ...

Forty years ago, the catastrophic explosion at Chernobyl sent plumes of radioactive waste into the atmosphere. Now, New Scientist has gained exclusive access to learn how vital work to decontaminate t ...

Lasting marketing clarity comes from timeless principles, not from whichever term trended on LinkedIn this quarter.

Researchers analyzed human, mouse, and clinical trial data and found PAM gene variants caused GLP‑1 resistance. The variants reduced the efficacy of GLP‑1 receptor agonists for blood glucose control.< ...

Voyager Therapeutics' anti-tau monoclonal antibody VY7523 demonstrated an excellent safety and PK profile in phase 1 SAD.